Nuvectis Pharma Inc. (NASDAQ: NVCT)
$4.7800
-0.1200 ( -3.24% ) 79.4K
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.
Market Data
Open
$4.7800
Previous close
$4.9000
Volume
79.4K
Market cap
$93.70M
Day range
$4.6420 - $5.1640
52 week range
$4.6420 - $12.1000
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 13 | Jun 13, 2024 |
4 | Insider transactions | 1 | Jun 13, 2024 |
4 | Insider transactions | 1 | May 15, 2024 |
4 | Insider transactions | 1 | May 13, 2024 |
4 | Insider transactions | 1 | May 13, 2024 |
4 | Insider transactions | 1 | May 13, 2024 |
8-k | 8K-related | 15 | May 07, 2024 |
10-q | Quarterly Reports | 48 | May 07, 2024 |
def | Proxies and info statements | 6 | Apr 29, 2024 |
4 | Insider transactions | 1 | Mar 19, 2024 |